Date:28/08/2004 URL: http://www.thehindu.com/2004/08/28/stories/2004082802101503.htm

Business - Briefly

USFDA nod for Ranbaxy's Gabapentin

CHENNAI: Ranbaxy Laboratories has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Gabapentin capsules. The drug is for the management of postherpetic neuralgia in adults, says a Bombay Stock Exchange release.